Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

在《新英格兰医学杂志》上发布的对照研究结论表明，使用Zepbound的患者在经过72周的治疗后体重平均减轻了50磅(约22.8公斤)，而使用Wegovy的患者体重 ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit management plans, the company announced on ...

礼来公司(LLY.US)于上周日宣布，根据一项头对头对比试验的数据，其减肥药物Zepbound在减少腰围等五项减肥指标上优于诺和诺德公司(NVO.US)的Wegovy。

The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in ...

For the first time, a study in The New England Journal of Medicine is comparing the most popular drugs for weight loss, ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy. The study, published in the New England Journal of ...